Zahra Bostani Khalesi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Zahra Bostani Khalesi has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
Maryam Niknami
Department of Midwifery, School of Nursing and Midwifery, Guilan University of Medical Sciences, Rasht, Iran
6 shared publicationsFatemeh Jafarzadeh-Kenarsari
Department of Midwifery School of Nursing and Midwifery Guilan University of Medical Sciences Rasht Iran
4 shared publicationsMahshid Bokaie
Research Center for Nursing and Midwifery Care, Shahid Sadoughi University of Medical Sciences , Yazd , Iran
4 shared publicationsSaman Maroufizadeh
Guilan University of Medical Sciences
4 shared publicationsSedighe Rezaie-Chamani
Social determinants of health research center, Guilan University of Medical Sciences, Rasht, Iran
4 shared publicationsSepideh Panjalipour
Guilan Univ Med Sci, Student Res Comm, Rasht, Iran
4 shared publications
Latest Publications
- Open Access
- 25 September 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Association between perceived social support and breastfeeding self-efficacy among iranian mothers: a cross-sectional study
- 25 September 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Open AccessAssociation between perceived social support and breastfeeding self-efficacy among iranian mothers: a cross-sectional study
- Open Access
- 20 August 2026
- Published by Springer Nature in BMC Public Health
Association between maternal health literacy and childbirth experience among postpartum women in Northern Iran: a cross-sectional study
- 20 August 2026
- Published by Springer Nature in BMC Public Health
Open AccessAssociation between maternal health literacy and childbirth experience among postpartum women in Northern Iran: a cross-sectional study
- Open Access
- 6 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Effect of multimedia-based education on maternal self-efficacy for preterm infant care in the NICU: a randomized controlled trial
- 6 August 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16  (1)
Open AccessEffect of multimedia-based education on maternal self-efficacy for preterm infant care in the NICU: a randomized controlled trial
- Open Access
- 23 July 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26  (1)
Efficacy and safety of non-hormonal pharmacotherapies for depressive and anxiety symptoms during the menopausal transition and postmenopause: a systematic review
Non-hormonal pharmacotherapies are widely used to manage depressive and anxiety symptoms in peri- and postmenopausal women, but comparative evidence across drug classes remains heterogeneous. To systematically evaluate the efficacy and safety of non-hormonal pharmacological interventions for depressive and anxiety symptoms during the menopausal transition and postmenopause. A systematic review of six databases and trial registries identified randomized and non-randomized studies evaluating SSRIs, SNRIs, gabapentinoids, and other pharmacotherapies. Due to substantial clinical and methodological heterogeneity, a structured Synthesis Without Meta-analysis (SWiM) approach was applied. A total of Thirty-one studies (n = 8,124 participants) were included. SNRIs showed more frequent positive effects on depressive symptoms compared with other pharmacological classes, while SSRIs demonstrated modest and variable effects. Gabapentinoids consistently improved vasomotor symptoms but showed limited and low-certainty effects on mood outcomes. Evidence for anxiety outcomes was inconsistent across all drug classes. Certainty of evidence ranged from very low to moderate. Non-hormonal pharmacotherapies may provide benefit for mood symptoms during the menopausal transition and postmenopause, particularly SNRIs; however, conclusions are limited by heterogeneity, indirectness, and lack of head-to-head comparative trials. Not applicable.
- 23 July 2026
- Published by Springer Nature in BMC Psychiatry
- Vol. 26  (1)
Open AccessEfficacy and safety of non-hormonal pharmacotherapies for depressive and anxiety symptoms during the menopausal transition and postmenopause: a systematic review
Non-hormonal pharmacotherapies are widely used to manage depressive and anxiety symptoms in peri- and postmenopausal women, but comparative evidence across drug classes remains heterogeneous. To systematically evaluate the efficacy and safety of non-hormonal pharmacological interventions for depressive and anxiety symptoms during the menopausal transition and postmenopause. A systematic review of six databases and trial registries identified randomized and non-randomized studies evaluating SSRIs, SNRIs, gabapentinoids, and other pharmacotherapies. Due to substantial clinical and methodological heterogeneity, a structured Synthesis Without Meta-analysis (SWiM) approach was applied. A total of Thirty-one studies (n = 8,124 participants) were included. SNRIs showed more frequent positive effects on depressive symptoms compared with other pharmacological classes, while SSRIs demonstrated modest and variable effects. Gabapentinoids consistently improved vasomotor symptoms but showed limited and low-certainty effects on mood outcomes. Evidence for anxiety outcomes was inconsistent across all drug classes. Certainty of evidence ranged from very low to moderate. Non-hormonal pharmacotherapies may provide benefit for mood symptoms during the menopausal transition and postmenopause, particularly SNRIs; however, conclusions are limited by heterogeneity, indirectness, and lack of head-to-head comparative trials. Not applicable.
- Open Access
- 1 February 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Effect of mobile phone app-based education on quality of life and menopausal symptoms in menopausal women
Objective: This study aimed to investigate the effect of mobile app–based education on menopausal symptoms and quality of life (QoL) among menopausal women attending an educational, research, and therapeutic center. Methods: This was a quasi-experimental study (educational intervention) with a controlled pre-test and post-test design. The study population included 86 menopausal women who were included in the study using convenience sampling and were then assigned into experimental and control groups by block randomization method. Data collection was carried out in the pre and post-intervention phases using individual–social and fertility characteristics form, Greene climacteric scale (GCS), and standard menopause-specific quality of life (MENQOL) questionnaire. The intervention group utilized the menopause mobile phone application for eight weeks. The control group did not receive any education. After the end of 8 weeks, GSC and MENQOL questionnaire were completed by the experimental and control groups via a phone call. Data analysis was also performed using independent t-test, paired t-test, and change-score analysis with p-value< 0.05 considered as the significance level in all tests. Results: Compared to the control group, the intervention group revealed a significant decrease in the average scores of all domains of QoL, the total score, and menopausal symptoms except for the sexual domain (p<0.01). Conclusion: The implementation of mobile phone app-based education can help improve QoL of menopausal women and reduce the severity of their menopausal symptoms. Hence, it can be used as an effective method for better management of menopausal symptoms and improving QoL of these women.
- 1 February 2026
- Published by SAGE Publications in Digital Health
- Vol. 12
Open AccessEffect of mobile phone app-based education on quality of life and menopausal symptoms in menopausal women
Objective: This study aimed to investigate the effect of mobile app–based education on menopausal symptoms and quality of life (QoL) among menopausal women attending an educational, research, and therapeutic center. Methods: This was a quasi-experimental study (educational intervention) with a controlled pre-test and post-test design. The study population included 86 menopausal women who were included in the study using convenience sampling and were then assigned into experimental and control groups by block randomization method. Data collection was carried out in the pre and post-intervention phases using individual–social and fertility characteristics form, Greene climacteric scale (GCS), and standard menopause-specific quality of life (MENQOL) questionnaire. The intervention group utilized the menopause mobile phone application for eight weeks. The control group did not receive any education. After the end of 8 weeks, GSC and MENQOL questionnaire were completed by the experimental and control groups via a phone call. Data analysis was also performed using independent t-test, paired t-test, and change-score analysis with p-value< 0.05 considered as the significance level in all tests. Results: Compared to the control group, the intervention group revealed a significant decrease in the average scores of all domains of QoL, the total score, and menopausal symptoms except for the sexual domain (p<0.01). Conclusion: The implementation of mobile phone app-based education can help improve QoL of menopausal women and reduce the severity of their menopausal symptoms. Hence, it can be used as an effective method for better management of menopausal symptoms and improving QoL of these women.
- Open Access
- 1 January 2026
- Published by Negah Scientific Publisher in Journal of Holistic Nursing and Midwifery
- Vol. 36  (1) , 26-36
Respectful Maternity Care and Associated Factors among Women from North of Iran
Introduction: Respectful Maternity Care(RMC), as one of the fundamental rights of women, can be effective in creating a positive experience of pregnancy and childbirth and increasing women's desire to have children and give vaginal birth. Objective: This study aims to determine the RMC status and its associated factors among women who ...
- 1 January 2026
- Published by Negah Scientific Publisher in Journal of Holistic Nursing and Midwifery
- Vol. 36  (1) , 26-36
Open AccessRespectful Maternity Care and Associated Factors among Women from North of Iran
Introduction: Respectful Maternity Care(RMC), as one of the fundamental rights of women, can be effective in creating a positive experience of pregnancy and childbirth and increasing women's desire to have children and give vaginal birth. Objective: This study aims to determine the RMC status and its associated factors among women who ...
- Open Access
- 30 December 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 1475
Policy Brief: An Evidence-Based Roadmap for the Equitable Elimination of HPV-Related Cancers by 2035
Background The convergence of highly effective prophylactic HPV vaccination and sensitive HPV-based screening technologies presents a historic opportunity to eliminate cervical cancer and reduce other HPV-related malignancies. Despite the availability of these tools, systemic inequities in access and implementation remain the principal barrier to achieving global elimination targets. Objective This policy brief synthesizes the latest evidence to provide an evidence-based, context-sensitive roadmap for policymakers to overcome health systems, economic, and political barriers, guiding the equitable elimination of HPV-related cancers by 2035. Key Recommendations Robust evidence confirms the high efficacy of HPV vaccination, including the transformative potential of single-dose schedules for improving equity and scalability. Primary HPV screening, particularly when coupled with self-sampling, offers superior protection and increases uptake. Success hinges on addressing critical implementation challenges. The brief outlines a comprehensive framework emphasizing: the adoption of gender-neutral and single-dose vaccination; integration of self-sampling and digital health tools; proactive interventions for marginalized groups; development of national investment cases; and the use of multi-sectoral task forces and community engagement to mitigate socio-cultural barriers. A phased three-year operational roadmap is proposed. Conclusion The elimination of HPV-related cancers is an achievable goal. This brief provides a strategic, evidence-informed pathway for policymakers to translate scientific progress into lasting population health impact through deliberate political commitment, financial investment, and health system reforms focused on equity.
- 30 December 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 1475
Open AccessPolicy Brief: An Evidence-Based Roadmap for the Equitable Elimination of HPV-Related Cancers by 2035
Background The convergence of highly effective prophylactic HPV vaccination and sensitive HPV-based screening technologies presents a historic opportunity to eliminate cervical cancer and reduce other HPV-related malignancies. Despite the availability of these tools, systemic inequities in access and implementation remain the principal barrier to achieving global elimination targets. Objective This policy brief synthesizes the latest evidence to provide an evidence-based, context-sensitive roadmap for policymakers to overcome health systems, economic, and political barriers, guiding the equitable elimination of HPV-related cancers by 2035. Key Recommendations Robust evidence confirms the high efficacy of HPV vaccination, including the transformative potential of single-dose schedules for improving equity and scalability. Primary HPV screening, particularly when coupled with self-sampling, offers superior protection and increases uptake. Success hinges on addressing critical implementation challenges. The brief outlines a comprehensive framework emphasizing: the adoption of gender-neutral and single-dose vaccination; integration of self-sampling and digital health tools; proactive interventions for marginalized groups; development of national investment cases; and the use of multi-sectoral task forces and community engagement to mitigate socio-cultural barriers. A phased three-year operational roadmap is proposed. Conclusion The elimination of HPV-related cancers is an achievable goal. This brief provides a strategic, evidence-informed pathway for policymakers to translate scientific progress into lasting population health impact through deliberate political commitment, financial investment, and health system reforms focused on equity.
- Open Access
- 1 December 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 5425-5438
Innovative Drug Delivery Systems for Management of Menopausal Symptoms: A Systematic Review
Menopause characterized by estrogen deficiency and has various symptoms, including vasomotor, genitourinary, and psychological manifestations. Innovative drug delivery systems (IDDSs) offer targeted approaches that increase therapeutic efficacy, reduce side effects, and improve patient adherence. To update our knowledge about Drug Delivery Systems (DDS) for decrease menopausal symptoms and its benefits compare with conventional systems. This review systematically examines the application and clinical potential of IDDS for managing menopause-related symptoms, with a particular emphasis on improvements in efficacy, safety, and patient adherence. A comprehensive literature search across multiple databases (PubMed, Em-base, Cochran, Scopus; 2001– 2024) yielded 23 studies, including RCTs and observational studies on trans dermal, intravaginal, and Nano-based DDS s (patches, vaginal rings, nano particles) and Neurokinin-3 (NK3) antagonists. Transdermal systems, such as estrogen patches, maintained stable hormone levels and reduced thromboembolism risk by 30% compared to oral hormone replacement therapy (HRT), by bypassing first-pass metabolism. Intravaginal DDS s, like estradiol rings, relieved genitourinary symptoms with less than 1% systemic absorption, thereby minimizing endometrial risks. Non-hormonal Neurokini3 antagonists like fezolinetant, decreased VMS by 60% and benefited high-risk patients. Emerging technologies, like hydro gels, showed preclinical potential but lack long-term safety data. Adherence to treatment was better with sustained-release formulations, such as pellet implants, compared to daily dosing regimens. DDSs offer personalized menopause management, balancing safety and efficacy. Future research should focus on pharmacogenomics, equity, and long-term safety of advanced DDSs, especially those using nanotechnology.
- 1 December 2025
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 17, 5425-5438
Open AccessInnovative Drug Delivery Systems for Management of Menopausal Symptoms: A Systematic Review
Menopause characterized by estrogen deficiency and has various symptoms, including vasomotor, genitourinary, and psychological manifestations. Innovative drug delivery systems (IDDSs) offer targeted approaches that increase therapeutic efficacy, reduce side effects, and improve patient adherence. To update our knowledge about Drug Delivery Systems (DDS) for decrease menopausal symptoms and its benefits compare with conventional systems. This review systematically examines the application and clinical potential of IDDS for managing menopause-related symptoms, with a particular emphasis on improvements in efficacy, safety, and patient adherence. A comprehensive literature search across multiple databases (PubMed, Em-base, Cochran, Scopus; 2001– 2024) yielded 23 studies, including RCTs and observational studies on trans dermal, intravaginal, and Nano-based DDS s (patches, vaginal rings, nano particles) and Neurokinin-3 (NK3) antagonists. Transdermal systems, such as estrogen patches, maintained stable hormone levels and reduced thromboembolism risk by 30% compared to oral hormone replacement therapy (HRT), by bypassing first-pass metabolism. Intravaginal DDS s, like estradiol rings, relieved genitourinary symptoms with less than 1% systemic absorption, thereby minimizing endometrial risks. Non-hormonal Neurokini3 antagonists like fezolinetant, decreased VMS by 60% and benefited high-risk patients. Emerging technologies, like hydro gels, showed preclinical potential but lack long-term safety data. Adherence to treatment was better with sustained-release formulations, such as pellet implants, compared to daily dosing regimens. DDSs offer personalized menopause management, balancing safety and efficacy. Future research should focus on pharmacogenomics, equity, and long-term safety of advanced DDSs, especially those using nanotechnology.
- Open Access
- 11 February 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25  (1) , 1
Correction: Anxiety, depression, and stress: a comparative study between couples with male and female infertility
- 11 February 2025
- Published by Springer Nature in BMC Women's Health
- Vol. 25  (1) , 1
Open AccessCorrection: Anxiety, depression, and stress: a comparative study between couples with male and female infertility